Not available outside of the UK & Ireland.
Application
Diazoxide has been used for diazoxide infusion. It has also been used to prevent depolarization for K+-induced exocytosis.
Biochem/physiol Actions
Selective ATP-sensitive K+ channel activator in both vascular smooth muscle and pancreatic β-cells; antihypertensive.
Features and Benefits
This compound is featured on the Potassium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
General description
Diazoxide is a nondiuretic benzothiadiazine, which is used for the treatment of hypoglycemia,von Gierke′s disease, acute and malignant hypertension. It acts as a beta cell KATP channel opener. Diazoxide prevents the secretion of insulin.
This product has met the following criteria: